Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group

Affiliations

• ¹ Y.Y. Leung, MB ChB, MD, Associate Professor, Duke-NUS Medical School, and Department of Rheumatology and Immunology, Singapore General Hospital, Singapore.
• ² A.M. Orbai, MD, MHS, Assistant Professor of Medicine, Director, Psoriatic Arthritis Program, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ³ W. Tillett, BSc, MB ChB, PhD, MRCP, Consultant Rheumatologist, Senior Lecturer, Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK.
• ⁴ A. Ogdie, MD, MSCE, Associate Professor of Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
• ⁵ L. Eder, MD, PhD, Women's College Research Institute, Women's College Hospital, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
• ⁶ N. Goel, MD, Patient Research Partner, Consultant, Caduceus Biomedical Consulting, LLC, and Adjunct Assistant Professor, Duke University School of Medicine, Durham, North Carolina, USA.
• ⁷ P. Hojgaard, MD, PhD, Department of Rheumatology, Holbaek Hospital, Holbaek, and the Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
• ⁸ R. Holland, MBBS, Concord Repatriation General Hospital, Sydney, Australia.
• ⁹ A.J. Mathew, MBBS, DNB, DM, Associate Professor in Rheumatology, Christian Medical College, Vellore, India and Clinical Research Fellow, Psoriatic Arthritis Program, University Health Network, University of Toronto, Toronto, Ontario, Canada.
• ¹⁰ C.A. Lindsay, PharmD, Patient Research Partner, VP Professional and Advocacy Relations, Aurinia Pharma U.S., Inc., Rockville, Maryland, USA.
• ¹¹ A. Antony, MBBS, Monash University School of Clinical Sciences, Monash Medical Centre, Clayton, Melbourne, Australia.
• ¹² J. Chau, GRAPPA Patient Research Partner, Hong Kong.
• ¹³ R. Christensen, BSc, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, and Professor of Biostatistics and Clinical Epidemiology, Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.
• ¹⁴ L.C. Coates, MB ChB, PhD, Associate Professor, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
• ¹⁵ P.J. Mease, MD, Rheumatology Research, Swedish Medical Center/Providence St. Joseph Health, and University of Washington School of Medicine, Seattle, Washington, USA.
• ¹⁶ V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA.
• ¹⁷ O. FitzGerald, MD, FRCPI, FRCP(UK), Consultant Rheumatologist and Newman Clinical Research Professor, Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.
• ¹⁸ M. de Wit, PhD, Patient Research Partner, Amsterdam, The Netherlands.
• ¹⁹ K. Callis Duffin, MD, MS, Department of Dermatology, University of Utah, Salt Lake City, Utah, USA.
• ²⁰ D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada.